Biomarker-driven mechanisms and therapeutic targets for prostate diseases through mendelian randomization and molecular docking
{{output}}
Background: Prostate diseases, comprising prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCA), represent substantial public health burdens. This study aimed to clarify biomarker-disease relationships and id... ...
